Login / Signup

5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging.

Elena Martínez-TerrobaCarmen BehrensJackeline AgorretaEduard MonsóLaura MillaresEnriqueta FelipRafael RosellJosé Luis RamirezAna RemirezWenceslao TorreIgnacio Gil-BazoMiguel A IdoateJuan Pablo de-TorresRuben PioIgnacio I WistubaMaría J PajaresLuis M Montuenga
Published in: Thorax (2018)
We have identified and validated a clinically feasible protein-based prognostic model that complements the updated TNM system allowing more accurate risk stratification. This signature may be used as an advantageous tool to improve the clinical management of the patients, allowing the reduction of lung SCC mortality through a more accurate knowledge of the patient's potential outcome.
Keyphrases